ANCA and ANA Testing in Retinal Hemorrhage
In a patient with retinal hemorrhage of unclear etiology, ANCA testing should be performed when there is clinical suspicion for systemic vasculitis (particularly ANCA-associated vasculitis), while ANA testing has limited direct utility for retinal hemorrhage evaluation unless there are features suggesting systemic lupus erythematosus or other connective tissue diseases.
When to Order ANCA Testing
Order ANCA testing (both PR3-ANCA and MPO-ANCA via high-quality immunoassay) if the patient presents with:
- Retinal hemorrhage accompanied by systemic symptoms suggesting vasculitis (constitutional symptoms, renal involvement, pulmonary symptoms, neuropathy, or skin manifestations) 1
- Retinal vascular occlusion (particularly central retinal artery occlusion) with unexplained etiology 2
- Scleritis or other inflammatory ocular manifestations alongside retinal hemorrhage 3
- Multi-organ involvement suggesting small-vessel vasculitis 4
The 2024 EULAR guidelines emphasize testing for both PR3-ANCA and MPO-ANCA using antigen-specific immunoassays as the primary screening method, as this approach has superior sensitivity (79.8-86.6% for PR3, though lower at 58.1% for MPO) and high specificity (96.8-98.3% for PR3, 95.6% for MPO) 1, 5.
Clinical Context for ANCA-Associated Vasculitis and Ocular Involvement
ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis) can cause retinal manifestations through small-vessel inflammation. Patients with ANCA-positive scleritis have significantly higher rates of severe ocular complications including retinal vascular involvement (86% vs 31% in ANCA-negative patients), worse visual outcomes, and more frequently have undiagnosed systemic vasculitis 3.
Key clinical indicators that should prompt ANCA testing:
- Retro-orbital lesions or pachymeningitis on imaging 1
- Concurrent renal dysfunction (hematuria, proteinuria, rising creatinine) 4
- Pulmonary-renal syndrome 4
- Peripheral neuropathy or mononeuritis multiplex 6
Role of ANA Testing
ANA testing has minimal direct utility for evaluating retinal hemorrhage itself, but should be considered when:
- Clinical features suggest systemic lupus erythematosus (malar rash, arthritis, serositis, cytopenias)
- There are overlapping autoimmune features
- Retinal vasculitis pattern suggests lupus retinopathy
Critical Pitfall: ANA Interference with ANCA Testing
A major caveat is that ANA positivity can cause false-positive ANCA results by indirect immunofluorescence (IIF), particularly false-positive C-ANCA patterns 7, 8, 9. When ANCA is positive by IIF but MPO/PR3 immunoassays are negative, consider ANA interference 7, 8. This is why current guidelines recommend primary screening with antigen-specific immunoassays (PR3/MPO ELISA) rather than IIF 1.
Practical Testing Algorithm
For retinal hemorrhage of unclear etiology:
Assess for systemic vasculitis features (constitutional symptoms, renal/pulmonary/neurologic involvement, inflammatory markers)
If vasculitis suspected: Order PR3-ANCA and MPO-ANCA by immunoassay (not IIF alone) 1
If ANCA positive: Do not delay treatment while awaiting biopsy if clinical presentation is compatible with AAV and patient is deteriorating 4
If ANCA positive by IIF but negative by immunoassay: Check ANA to rule out interference 7, 8
Consider ANA testing separately only if clinical features suggest lupus or other connective tissue disease
Negative ANCA does not exclude AAV - approximately 10% of patients with AAV are ANCA-negative, particularly those with limited disease 1, 4
Additional Considerations
- In patients with pulmonary-renal syndrome, also test for anti-GBM antibodies as dual positivity affects prognosis and may require plasma exchange 1, 4
- ANCA status provides prognostic information: MPO-ANCA positivity associates with more renal/neurologic involvement, while ANCA-negative EGPA has more cardiac/pulmonary manifestations 6
- Serial ANCA monitoring is not recommended for treatment decisions - use structured clinical assessment instead 10
The key is recognizing that retinal hemorrhage alone does not warrant routine ANCA/ANA screening, but these tests become essential when systemic features suggest underlying vasculitis or autoimmune disease that could be vision- and life-threatening if untreated.